Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells

Abstract Tamoxifen resistance is emerging as a big challenge in endocrine therapy of luminal A breast cancer patients. In this study, we aimed to determine the molecular changes of PI3K/AKT/PTEN signaling pathway during tamoxifen-resistance development using gradually increased doses of tamoxifen in...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lama Hamadneh, Rama Abuarqoub, Ala Alhusban, Mohamad Bahader
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2020
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/67fff4cce9114647897b2e2d4a2af510
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:67fff4cce9114647897b2e2d4a2af510
record_format	dspace
spelling	oai:doaj.org-article:67fff4cce9114647897b2e2d4a2af5102021-12-02T11:57:58ZUpregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells10.1038/s41598-020-78833-x2045-2322https://doaj.org/article/67fff4cce9114647897b2e2d4a2af5102020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-78833-xhttps://doaj.org/toc/2045-2322Abstract Tamoxifen resistance is emerging as a big challenge in endocrine therapy of luminal A breast cancer patients. In this study, we aimed to determine the molecular changes of PI3K/AKT/PTEN signaling pathway during tamoxifen-resistance development using gradually increased doses of tamoxifen in one model, while fixing tamoxifen treatment dose at 35 μM for several times in the second model. An upregulation of AKT/PI3K genes was noticed at 30 μM tamoxifen concentration in cells treated with a gradual increase of tamoxifen doses. In the second model, significant upregulation of AKT1 was seen in cells treated with 35 μM tamoxifen for three times. All genes studied showed a significant increase in expression in resistant cells treated with 50 µM and 35 µM six times tamoxifen. These genes’ upregulation was accompanied by PTEN and GSK3 ß genes’ down-regulation, and it was in correlation to the changes in the metabolic rate of glucose in tamoxifen-resistant models. A significant increase in glucose consumption rate from culture media was observed in tamoxifen resistant cells with the highest consumption rate reported in the first day of culturing. Increased glucose consumption rates were also correlated with GLUL significant gene expression and non-significant change in c-MYC gene expression that may lead to increased endogenous glutamine synthesis. As a result, several molecular and metabolic changes precede acquired tamoxifen resistance could be used as resistance biomarkers or targets to reverse tamoxifen resistance.Lama HamadnehRama AbuarqoubAla AlhusbanMohamad BahaderNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-7 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Lama Hamadneh Rama Abuarqoub Ala Alhusban Mohamad Bahader Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells
description	Abstract Tamoxifen resistance is emerging as a big challenge in endocrine therapy of luminal A breast cancer patients. In this study, we aimed to determine the molecular changes of PI3K/AKT/PTEN signaling pathway during tamoxifen-resistance development using gradually increased doses of tamoxifen in one model, while fixing tamoxifen treatment dose at 35 μM for several times in the second model. An upregulation of AKT/PI3K genes was noticed at 30 μM tamoxifen concentration in cells treated with a gradual increase of tamoxifen doses. In the second model, significant upregulation of AKT1 was seen in cells treated with 35 μM tamoxifen for three times. All genes studied showed a significant increase in expression in resistant cells treated with 50 µM and 35 µM six times tamoxifen. These genes’ upregulation was accompanied by PTEN and GSK3 ß genes’ down-regulation, and it was in correlation to the changes in the metabolic rate of glucose in tamoxifen-resistant models. A significant increase in glucose consumption rate from culture media was observed in tamoxifen resistant cells with the highest consumption rate reported in the first day of culturing. Increased glucose consumption rates were also correlated with GLUL significant gene expression and non-significant change in c-MYC gene expression that may lead to increased endogenous glutamine synthesis. As a result, several molecular and metabolic changes precede acquired tamoxifen resistance could be used as resistance biomarkers or targets to reverse tamoxifen resistance.
format	article
author	Lama Hamadneh Rama Abuarqoub Ala Alhusban Mohamad Bahader
author_facet	Lama Hamadneh Rama Abuarqoub Ala Alhusban Mohamad Bahader
author_sort	Lama Hamadneh
title	Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells
title_short	Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells
title_full	Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells
title_fullStr	Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells
title_full_unstemmed	Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells
title_sort	upregulation of pi3k/akt/pten pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in mcf-7 cells
publisher	Nature Portfolio
publishDate	2020
url	https://doaj.org/article/67fff4cce9114647897b2e2d4a2af510
work_keys_str_mv	AT lamahamadneh upregulationofpi3kaktptenpathwayiscorrelatedwithglucoseandglutaminemetabolicdysfunctionduringtamoxifenresistancedevelopmentinmcf7cells AT ramaabuarqoub upregulationofpi3kaktptenpathwayiscorrelatedwithglucoseandglutaminemetabolicdysfunctionduringtamoxifenresistancedevelopmentinmcf7cells AT alaalhusban upregulationofpi3kaktptenpathwayiscorrelatedwithglucoseandglutaminemetabolicdysfunctionduringtamoxifenresistancedevelopmentinmcf7cells AT mohamadbahader upregulationofpi3kaktptenpathwayiscorrelatedwithglucoseandglutaminemetabolicdysfunctionduringtamoxifenresistancedevelopmentinmcf7cells
_version_	1718394752462749696

Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells

Ejemplares similares